Brief: Nanoform Finland Partners With Pharmanovia
July 14 (Reuters) -
* PARTNERED WITH PHARMANOVIA, SPECIALTY PHARMA BUSINESS WITH
A
PORTFOLIO OF OVER 20 BRANDED DRUGS IN 140 MARKETS
* NEW STRATEGIC PARTNERSHIP AIMS TO ADD VALUE TO BRANDED
PRESCRIPTION MEDICINES
* PHARMANOVIA WILL LOOK TO APPLY NANOFORM'S PROPRIETARY
NANOPARTICLE TECHNOLOGIES
Source text for Eikon: ID:nWkr66WFZZ
Further company coverage: NANOFH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nanoform Finland Oyj
See all newsFinland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cuts
Brief: Nanoform Q2 EBITDA EUR -3 Million
Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
Finland's Nanoform Q1 revenue rises 45%, EBITDA loss narrows
Brief: Nanoform Finland Targets Cash Burn Below EUR 10 Mln For 2026